Golsa Zeiarati is a pharmacist who is specialized in Geriatric in Ossining, New York. Patients can reach her at 19 Minkel Rd, Ossining or contact her on 914-572-7708. Active license number of Golsa Zeiarati is 054254 for Geriatric in New York. Golsa Zeiarati is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Golsa Zeiarati speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Golsa Zeiarati
Specialization:
Geriatric
Credentials:
PHARMD
Gender:
Female
Location:
19 Minkel Rd, Ossining, New York, 10562-2127
Phone:
914-572-7708
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Golsa Zeiarati are as mentioned below.
NPI Number:
1396396206
NPI Enumeration Date:
23 Sep, 2019
NPI Last Update On:
23 Sep, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Golsa Zeiarati are as mentioned below.
Specialization
License Number
State
Status
Geriatric
054254
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
19 Minkel Rd, Ossining, New York
Zip:
10562-2127
Phone Number:
914-572-7708
Fax Number:
--
Patients can reach Golsa Zeiarati at 19 Minkel Rd, Ossining, New York or can call on phone at 914-572-7708.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.